Compare IDYA & VC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | VC |
|---|---|---|
| Founded | 2015 | 2000 |
| Country | United States | United States |
| Employees | N/A | 10000 |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Parts:O.E.M. |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | 2019 | 2000 |
| Metric | IDYA | VC |
|---|---|---|
| Price | $31.70 | $100.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 14 |
| Target Price | $52.86 | ★ $120.75 |
| AVG Volume (30 Days) | ★ 1.5M | 468.9K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.48% |
| EPS Growth | ★ 61.90 | N/A |
| EPS | N/A | ★ 7.28 |
| Revenue | $218,710,000.00 | ★ $3,768,000,000.00 |
| Revenue This Year | N/A | $2.39 |
| Revenue Next Year | $201.05 | $5.21 |
| P/E Ratio | ★ N/A | $13.92 |
| Revenue Growth | ★ 3024.43 | N/A |
| 52 Week Low | $16.82 | $75.11 |
| 52 Week High | $39.28 | $128.32 |
| Indicator | IDYA | VC |
|---|---|---|
| Relative Strength Index (RSI) | 46.97 | 64.48 |
| Support Level | $29.51 | $96.66 |
| Resistance Level | $34.76 | $106.35 |
| Average True Range (ATR) | 2.02 | 3.15 |
| MACD | 0.09 | 1.08 |
| Stochastic Oscillator | 19.44 | 77.67 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda, etc. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America and Others.